Featured Research

from universities, journals, and other organizations

More Studies Needed To Determine Genetic Controls Of Il-4 Receptors In Allergies and Asthma, According To National Jewish Medical And Research Center Physician

Date:
December 10, 1997
Source:
National Jewish Medical And Research Center
Summary:
A National Jewish researcher who earlier reported genetic variations of interleukin-4 in people predisposed to asthma and allergies writes in tomorrow’s edition of the New England Journal of Medicine that new research increasing understanding of the role of IL-4 receptors in genetic predisposition to these diseases deserves continued exploration.

DENVER-A National Jewish Medical and Research Center researcher who earlier reported genetic variations of interleukin-4 in people predisposed to asthma and allergies writes in today’s edition of the New England Journal of Medicine that new research increasing understanding of the role of IL-4 receptors in genetic predisposition to these diseases deserves continued exploration.

"Research on genetic variations of IL-4 and IL-4 receptors will have value as markers for susceptibility and as models that may lead to innovative treatments for allergic disease and asthma," said Lanny Rosenwasser, M.D., head, Division of Allergy and Clinical Immunolgy at National Jewish.

The new research expands scientists’ understanding of IL-4 receptors. IL-4, a type of protein, or cytokine, released by cells when they come in contact with an allergen, causes the body’s immune system to release substances that cause inflammation in diseases such as asthma. IL-4 is also instrumental in causing the immune sytem to produce the allergic antibody IgE. When activated by an allergen entering the body, IL-4 binds to IL-4 receptors causing a series of immune responses by cells. These responses can cause inflammation of the airways.

In clinical trials at National Jewish, researchers are using a soluble form of IL-4 receptors to treat people with asthma who have a particularly high number of the IL-4 receptors. Researchers hope to "turn off" IL-4’s immune response to allergens.

For more information about National Jewish, call (800) 222-LUNG or visit http://www.nationaljewish.org/pa.


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "More Studies Needed To Determine Genetic Controls Of Il-4 Receptors In Allergies and Asthma, According To National Jewish Medical And Research Center Physician." ScienceDaily. ScienceDaily, 10 December 1997. <www.sciencedaily.com/releases/1997/12/971210111137.htm>.
National Jewish Medical And Research Center. (1997, December 10). More Studies Needed To Determine Genetic Controls Of Il-4 Receptors In Allergies and Asthma, According To National Jewish Medical And Research Center Physician. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/1997/12/971210111137.htm
National Jewish Medical And Research Center. "More Studies Needed To Determine Genetic Controls Of Il-4 Receptors In Allergies and Asthma, According To National Jewish Medical And Research Center Physician." ScienceDaily. www.sciencedaily.com/releases/1997/12/971210111137.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins